Yao YL, Xu B, Song YG, Zhang WD. Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori- induced gastric precancerosis. World J Gastroenterol 2002; 8(1): 60-63
Corresponding Author of This Article
Yong-Li Yao, Institute of Gastrointestinal Diseases, Nanfang Hospital, First Military medical University, Guangzhou 510515, Guangdong Province, China. firstname.lastname@example.org
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Feb 15, 2002; 8(1): 60-63 Published online Feb 15, 2002. doi: 10.3748/wjg.v8.i1.60
Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori- induced gastric precancerosis
Yong-Li Yao, Bo Xu, Yu-Gang Song, Wan-Dai Zhang
Yong-Li Yao, Yu-Gang Song, Wan-Dai Zhang, Institute of Gastrointestina l Diseases, Nanfang Hospital, First Military Medical University, Guangzhou 510515, Guangdong Province, China
Bo Xu, Department of Orthopedics, Nanfang Hospital, First Military Medical University, Guangzhou 510515, Guangdong Province, China
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Correspondence to: Yong-Li Yao, Institute of Gastrointestinal Diseases, Nanfang Hospital, First Military medical University, Guangzhou 510515, Guangdong Province, China. email@example.com
Received: March 12, 2001 Revised: July 2, 2001 Accepted: August 15, 2001 Published online: February 15, 2002
AIM: To explore dysregulation of cyclin E in malignancies, and to further investigate the role of cyclin E in Helicobacter pylori (H. pylori)-induced gastric precancerosis.
METHODS: Four-week-old specific pathogen-free male Mongolian gerbils were employed in the study. 0.5 mL 1 × 108 cfu·L-1 suspension of H. pylori NTCC11637 in Brucella broth was inoculated orally into each of 20 Mongolian gerbils, and a further 20 gerbils were inoculated with Brucella broth as controls. 10 of the infected gerbils and 10 of the non-infected control gerbils were sacrificed at 25, 45 wk after infection. The expression of cyclin E was analyzed by RT-PCR and immunohistochemical studies with monoclonal antibody to cyclin E in Mongolian gerbil of H. pylori-induced gastric precancerosis.
RESULTS: H. pylori was constantly detected in all infected animals throughout the study. At 25 wk after infection of H. pylori. ulcers were observed in the antral and body of stomach (n = 6). Histological examination showed that all animals developed severe inflammation and multifocal lymphoid follicles appeared in the lamina propria and submucosa of gastric antrum. At 45 wk after infection of H. pylori, severe atrophic gastritis (n = 10). intestinal metaplasia (n = 8) and dysplasia (n = 6) could be observed. Cyclin E mRNA levels were significantly more at 25 wk after infection of H. pylori (1.27 ± 0.26), and at 45 wk after infection of H. pylori ( 1.82 ± 0.39) than control-animals (0.59 ± 0.20,P < 0.01); cyclin E mRNA levels were evaluated by 2.2-fold at 25 wk (P < 0.01) and 3.1-fold at 45 wk (P < 0.01) precancerosis induced by H. pylori, when compared with control gastric epithelium of Mongolian gerbil. Immunohistochemical staining revealed exclusive nuclear staining of cyclin E. Furthermore, there was a sequential increase in cyclin E positive cells from normal epithelium to precancerosis.
CONCLUSION: Overexpression of cyclin E occurs relatively early in gastric tumorigenesis in this model.
Key Words: $[Keywords]
Citation: Yao YL, Xu B, Song YG, Zhang WD. Overexpression of cyclin E in Mongolian gerbil with Helicobacter pylori- induced gastric precancerosis. World J Gastroenterol 2002; 8(1): 60-63
Gastric cancer is a major health problem[1-3] and remains the second most common cancer in the world[4-6]. Although epidemiological studies have indicated that H. pylori infection plays a crucial role in gastric carcinogenesis in humans[7-22], there is no direct proof that H. pylori is actually associated with gastric carcinogenesis[23-26]. The purpose of this study was to elucidate the relationship between H. pylori infection and gastric carcinogenesis by using an animal model of long-term H. pylori infection, and explore the role played by cyclin E in gastric tumorigenesis[27-29].
Cyclins are positive regulators of cell cycle progression. They function by forming a complex with and activating a class of protein kinases which are essential for cell cycle transitions. As the major regulatory events leading to cell proliferation occur in the G1 phase of the cell cycle, altered expression of cyclins involved in the G1 phase may be an important step in oncogenesis[30-33]. Among G1 cyclins, an accumulating body of evidence suggests that over expression and rearrangement of cyclin E is associated with malignancy. Over expression of cyclin E has also been found in mouse mammary tumors and is associated iwth tumor development; altered expression of cyclin E can accelerate occurrence and early progression of colorectal cancer, and plays an important role in occurrence of breast cancer[34-37]. But cyclin D1, over expression in esophageal cancer and breast cancer, has no over expression in gastric cancer, which suggests expression of cyclins has specificity of organs. To gain a further understanding of the role played by cyclin E in gastric tumorigenesis, the study investigates the role of cyclin E in H. pylori-induced gastric precancerosis[38-39].
MATERIALS AND METHODS
Animals and preparation
Four-week-old specific pathogen-free male Mongolian gerbils, weighing (20 ± 5) g, were employed in the study. They were housed in individual metabolic cages in a temperature conditioned room (23 ± 2) °C with a 12 h light-dark cycle, allowed access to standard rat chow (provided by Experimental Animal Center, First Military Medical University) and water ad labium, and acclimatized to the surrounding for 7 d prior to the experiments. H. pylori (NTCC11637) was obtained from American Type Culture Collection and cultured on Brucella agar plates containing 70 mL·L-1 goat blood in a microaerobic condition (volume fraction; N2 : 85%, O2 : 5%, CO2 : 10%, in aerobic globe box) at 37 °C for 3 d. The strain was identified by morphyology, Gram’s stain, urease production and so on.
Suspension 0.5 mL 1 × 108 cfu·L-1 of H. pylori NTCC11637 in Brucella broth was inoculated orally into each of 20 Mongolian gerbils which had been fasted overnight, for 14 d continuously. A further 20 gerbils were inoculated with Brucella broth as controls. 10 of the infected gerbils and 10 of the non-infected control gerbils were sacrificed at 25, 45 wk after infection. The stomach of each animal was removed and opened for macroscopic observation. For half of each gastric antrum mucosa was dissected for RNA isolation. The remainders of the stomach samples were used for istological examination, which were fixed with neutral-buffered 100 mL·L-1 formalin and processed by standard methods that embedded in paraffin, sectioned and stained with haematoxylin for analyzing histological changes, Giemsa stain for detecting for H. pylori and Alcian blue (AB)/PAS stain for examining intestinal metaplasia.
RNA isolation and RT-PCR analysis
Using Tripure isolation reagent (Boehringer Mannheim, Germany), total cellular RNA was isolated from previously frozen tissues according to the manufacturer’s instruction. All RNA samples were analyzed for integrity of 18 s and 28 s rRNA by ethiding bromide staining of 0.5 µg RNA resolved by electrophoresis on 12 g·L-1 agarose-formaldehyde gels. RT-PCR analysis was performed as follows. RNA was incubated at 60 °C for 10 min and chilled to 4 °C immediately before being reverse transcribed. Reverse transcription of 1 µg total RNA using antisense primers was performed in a volume of 20 µL for 40 min at 50 °C, containing 200 U MMLV reverse transcriptase, 1 × buffer RT, 1 MU·L-1 Rnasin, 0.5 mmol·L-1 dATP, dGTP, dCTP and dTTP respectively and 0.2 µmol·L-1 antisense primers including cyclin E and β-actin respectively. The samples were heated to 99 °C for 5 min to terminate the reverse transcription reaction. By using a Perkin-Elmer DNA Thermocycler 4800 (Perkin-Elmer, Norwalk, CT), 5 µL cDNA mixture obtained from the reverse transcription reaction was then amplified for cyclin E and β-actin. β-actin was used as the housekeeping gene and amplified with cyclin E as contrast. The amplification reaction mixture consisted of 10 × buffer 5 µL, 0.2 mmol·L-1 dATP, dGTP, dCTP and dTTP respectively, 2.5 U Taq DNA polymerase, and 0.2 µmol·L-1 each of sense and antisense primers in a final volume of 50 µL. The reaction mixture was first heated at 94 °C for 2 min and amplification was carried out for 29 cycles at 94 °C for 0.5 min, 53 °C for 1 min, 70 °C for 1.5 min, followed by an incubation for 7 min at 70 °C. The number of amplification cycles was previously determined to keep amplification in the linear range to avoid the “plateau effect” associated with increased numbers of PCR cycles. The PCR primers used were: cyclin E, sense 5’-TATGGCGACACAAGAAAATG-3’ and antisense 5’-GCAAGAGAAGACAGACAACG-3’; β-actin, sense 5’-CCAAGGCCAACCGCGAGAAGATGAC-3’ and antisense 5’-AGGGTACATGGTGGTGCCGCCAGAC-3’. The length of PCR products for cyclin E and β-actin was 770 bp and 587 bp. PCR products were run on a 15 g·L-1 agarose gel in 0.5 × TBE buffer and then analyzed by gel image analysis system. The level of cyclin E was reflected with the ratio of cyclin E/β-actin.
Four micrometers paraffin-embedded tisue sections were deparaffinized and rehydrated. Endogenous peroxidase activity was ablated with 10 mL·L-1 hydrogenperoxide in methanol. The immunostaining for cyclin E was conduced using the StreptAvidin-Biotin-enzyme Complex kit (Boster, Wuhan). Immunostaining by replacing primary antibody with PBS was also conducted as a negative control. The staining was evaluated semiquantitatively on the basis of the percentage of positive cells, and classified as follows: diffusely positive (+++) when positive cells accounted for more than 70% of the total cells, partially positive (++) when positive cells were 35%-70%, partially positive (+) when positive cells accounted for 5%-35%, and negative (-) when positive cells accounted for less than 5%.
Experimental results were analyzed with Chi-square Tests and K Related Samples Test by SPSS software. Statistical significance was determined at P < 0.05.
H. pylori was detected in gastric antrum and gastric body of all infected animals throughout the study, and more in gastric antrum than gastric body. By the 25th wk after infection of H. pylori, ulcers were observed in the antral and body of stomach (n = 6). Histological examination showed that all animals developed severe inflammation in the area close to ulcers; multifocal lymphoid follicles appeared in the lamina propria and submucosa; and there were mild atrophic gastritis in all infected animals. By the 45th wk after infection of H. pylori, severe atrophic gastritis (n = 10), intestinal metaplasia (n = 8) and dysplasia (n = 6) could be observed. Those metaplastic glands appeared more atypical than the surrounding nonmetaplastic and hyperplastic glands. Severe atrophic gastritis, intestinal metaplasia and dysplasia were gastric precancerosis. In the uninfected animals, there were no significant changes throughout the study.
RT-PCR analysis of cyclin E mRNA expression
There were cyclin E mRNA expression in gastric anturm mucosa of control-animals. cyclin E mRNA levels were significantly more at 25 wk after infection of H. pylori(1.27 ± 0.26), and at 45 wk after infection of H. pylori(1.82 ± 0.39) than control-animals (0.59 ± 0.20, P < 0.01); Cyclin E mRNA levels were evaluated by 2.2-fold at 25 wk (P < 0.01) and 3.1-fold at 45 wk (P < 0.01) precancerosis induced by H. pylori, when compared with control gastric epithelium of Mongolian gerbil (Figures 1, 2 and 3).
Figure 1 1:cyclin E; 2:PCR marker; 3:β -actin.
Figure 2 RT-PCR analysis of cyclin E mRNA levels using β -actin as internal control.
Total RNA was first reverse transcribed into cDNA and then amplified by PCR in control.
Figure 3 In 25 wk after infection of H.
Immunohistochemical analysis of cyclin E protein expression
To examine whether increased cyclin E mRNA expression were accompanied by increased expression of cyclin E protein, imunohistochemical analysis was performed. cyclin E protein expression lied in nuclei and cytoplasm. Cyclin E protein expressions were evaluated significantly at 25 wk(P < 0.01) and at 45 wk (P < 0.01) precancerosis induced by H. pylori, when compared with control gastric epithelium of Mongolian gerbil (Figure 4 and Table 1).
Table 1 Expression of cyclin E by immunohistochemical staining (n = 10).
K related samples test: P = 0.002Chi-square test: χ2 = 12.344,P = 0.002bvs
aP = 0.007, c vsaP = 0.002
Figure 4 In 45 wk after infection of H.
H. pylori infection is now know as a major cause of acute and chronic active gastritis, peptic ulcer disease and atrophic gastritis and is also suspected to be involved in the genesis of gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma[41-49]. In 1994, the International Agency for Research on Cancer (IRAC), a branch of the World Health Organization (WHO), convened experts from 11 countries to examine the evidence linking a number of infectious agents with human cancer. Although there is no direct proof that H. pylori is actually associated with gastric carcinogenesis, epidemiological studies have indicated that H. pylori infection plays an important role in gastric carcinogenesis in humans; H. pylori was designated as a definite carcinogen (group I) to the human stomach based on prospective case-control studies reported in 1991. Several experiments were conducted in Japan that demonstrated that chronic H. pylori-infection models of Mongolian gerbils developed gastric carcinoma. These results will be extremely significant to elucidate the mechanism of gastric carcinogenesis due to H. pylori infection[5,50]. Apoptosis, a programmed cell death, was ignored, just like H. pylori, only to reappear recently. However, the number of current publications dealing with apoptosis of H. pylori has increased exponentially. Although gastric epithelial apoptosis is a programmed physiological event in the superficial aspect of the mucosa and is important for healthy cell turnover, H. pylori infection reportedly promotes such a cell death sequence[51-52]. Because apoptosis regulates the cycle of cell turnover in balance with proliferation, dysregulation of apoptosis or proliferation evoked by H. pylori colonization would be linked to the gastric carcinogenesis[53-56].
Cyclins are positive regulators of cell cycle progression, initially identified in early cleavage embryos of marine invertebrates as proteins that accumulated during interphase and were degraded at mitosis. Cyclins are now known to be positive regulatory subunits of a class of protein kinase termed cyclin-dependent kinases. These protein kinases have been shown in a number of diverse eukaryotic systems to be the master regulators of major cell cycle transitions[57-59]. Cyclin E is essential for the G1/S phase transitionin the cell cycle. Cyclin E gene amplification and altered expression has been reported in a variety of human cancers[60-61]. Now Cyclin E gene has been defected as oncogene. Cyclin E was synthetized in the mid-term of the cell cycle, expressed the highest level when entering S phase, and degraded through S phase. The level of cyclin-dependent kinase2 kept constant during the cell cycle. Cyclin E, cyclin-dependent kinase2 and cyclin-dependent kinase inhibitor regulated G1/S phase transition by two-way at late stage of G1 phase, Cyclin E accelerated G1/S phase transition by composing and activating cyclin-dependent kinase2.
In the present study, to explore dysregulation of cyclin E in malignancies, and to further investigate the role of cyclin E in H. pylori-induced gastric precancerosis, cyclin E mRNA level was measured by quantitative RT-PCR analysis in Mongolian gerbil gastric antrum mucosa. In addition, the expression and localization of protein product was analyzed by immunohistochemistry. Sample size requirement for obtaining sufficient amounts of RNA for RT-PCR analysis did not allowdetection of either cyclin E mRNA level in any specific type of preneoplastic lesions. However, using immunohistochemical technique, cyclin E protein expression in preneoplastic lesions was observed from paraffin-embedded tissue sections. Cyclin E mRNA levels were increased 2.2-fold at 25 wk and 3.1-fold at 45 wk precancerosis induced by H. pylori, when compared with normal gastric epithelium of Mongolian gerbil. Immunohistochemical staining revealed exclusive nuclear staining of cyclin E. Furthermore, there was a sequential increase in cyclin E positve cells from normal epithelium to precancerosis. The present study indicated that expression of cyclin E increased from normal epithelium to precancerosis, dysregulation of cyclin E expression occurred relatively early in gastric tumorigenesis in this model and might participate in tumor progression. These findings suggested that H. pylori-induced gastric precancerosis was associated with dysregulation of gastric epithelial cell cycle. Further studies were needed to delineate the mechanism of these alterations.
Edited by Wang JH and Xu XQ
Deng DJ. progress of gastric cancer etiology: N-nitrosamides 1999s.World J Gastroenterol. 2000;6:613-618.
Chen GY, Wang DR. The expression and clinical significance of CD44v in human gastric cancers.World J Gastroenterol. 2000;6:125-127.
Ma JL, Liu WD, Zhang ZZ, Zhang L, You WC, Chang YS. Relation-ship between gastric cancer and precancerous lesions.Shijie Huaren XiaoHua Zazhi. 1998;6:223-224.
Pan ZR. Study on chronic gastritis and gastric cancer.Xin Xiaohua Bingxue Zazhi. 1996;4:95-96.
Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils.Gastroenterology. 1998;115:642-648.
Zhuang XQ, Lin SR. Study on the relationship between Helicobactr pylori and gastric cancer.Shijie Huaren XiaoHua Zazhi. 2000;8:206-207.
Vandenplas Y. Helicobacter pylori infection.World J Gastroenterol. 2000;6:20-31.
Takahashi S, Keto Y, Fujita H, Muramatsu H, Nishino T, Okabe S. Pathological changes in the formation of Helicobacter pylori-induced gastric lesions in Mongolian gerbils.Dig Dis Sci. 1998;43:754-765.
Pan KF, Liu WD, Ma JL, Zhou T, Zhang L, Chang YS, You WC. Infection of Helicobacter pylori in children and mode of transmission in a high-risk area of gastric cancer.Shijie Huaren XiaoHua Zazhi. 1998;6:42-44.
Zhang L, Jiang J, Pan KF, Liu WD, Ma JL, Zhou T, Perez-Perez GT, Blaser MJ, Chang YS, You WC. Infection of H. pylori with cagA strain in a high risk area of gastric cancer.Shijie Huaren XiaoHua Zazhi. 1998;6:40-41.
Zhuang XQ, Lin SR. Study on Helicobacter pylori infection in gastric cancer and precancerosis. Shijie Huaren Xiaohua Zazhi 2000; 8: 710-711.
Hu PJ. Helicobacter pylori and gastric cancer.Shijie Huaren XiaoHua Zazhi. 1999;7:1-2.
Huang XQ. Helicobacter pylori infection and gastrointestinal hormones: a review.World J Gastroenterol. 2000;6:783-788.
Wang XH, Zahgn WD, Zahgn YL, Zeng JZ, Sun Y. Relationship between Hp infection and oncogene and tumor suppressor gene expressions in gastric cancer and precancerosis.Shijie Huaren XiaoHua Zazhi. 1998;6:516-518.
Ye GA, Zhang WD, Liu LM, Shi L, Xu ZM, Chen Y, Zhou DY. Hp vac A gene and chronic gastritis. Shijie Huaren XiaoHua Zazhi. 2001;593-594.
Quan J, Fan XG. Experimental studies on Helicobacter pylori and gastric cancer.Shijie Huaren XiaoHua Zazhi. 1999;7:1068-1069.
Lu SY, Pan XZ, Peng XW, Shi ZL, Lin L, Chen MH. Effect of Hp infection on gastric epithelial cell kinetics in stomach diseases.Shijie Huaren XiaoHua Zazhi. 2000;8:386-388.
Harry XH. Association between Helicobacter pylori and gastric cancer: current knowledge and future research.World J Gastroenterol. 1998;4:93-96.
Gao XH, Pan BR. Helicobacter pylori infection and gastric cancer.Xin Xiaohua Bingxue Zazhi. 1995;3:223-224.
Zu Y, Shu J, Yang CM, Zhong ZF, Dai HY, Wang X, Qin GM. Study on Helicobacter pylori infection and risk of gastric cancer.Shijie Huaren XiaoHua Zazhi. 1998;6:367-368.
Wu MS, Shun CT, Lee WC, Chen CJ, Wang HP, Lee WJ, Lin JT. Gastric cancer risk in relation to Helicobacter pylori infection and subtypes of intestinal metaplasia.Br J Cancer. 1998;78:125-128.
Forman D. Review article: Is there significant variation in the risk of gastric cancer associated with Helicobacter pylori infection.Aliment Pharmacol Ther. 1998;12 Suppl 1:3-7.
Alexander GA, Brawley OW. Association of Helicobacter pylori infection with gastric cancer.Mil Med. 2000;165:21-27.
Cai L, Yu SZ, Zhang ZF. Helicobacter pylori infection and risk of gastric cancer in Changle County,Fujian Province,China.World J Gastroenterol. 2000;6:374-376.
Chi J, Fu BY, Nakajima , Hatorri and Kushima. Establishment of Mongolian gerbil animal model infected with Hp infection and change of inflammation and proliferation before and after Hp eradication.Shijie Huaren XiaoHua Zazhi. 1999;7:557-560.
Zhang WD. Animal model on diseases induced by H. pylori: it was difficult for study of H. pylori.Shijie Huaren XiaoHua Zazhi. 1999;7:555-556.
Yasui W, Naka K, Suzuki T, Fujimoto J, Hayashi K, Matsutani N, Yokozaki H, Tahara E. Expression of p27Kip1, cyclin E and E2F-1 in primary and metastatic tumors of gastric carcinoma.Oncol Rep. 1999;6:983-987.
Matsumoto M, Furihata M, Ishikawa T, Ohtsuki Y, Ogoshi S. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma.Br J Cancer. 1999;80:256-261.
Lodén M, Nielsen NH, Roos G, Emdin SO, Landberg G. Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation.Oncogene. 1999;18:2557-2566.
Le Cam L, Polanowska J, Fabbrizio E, Olivier M, Philips A, Ng Eaton E, Classon M, Geng Y, Sardet C. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.EMBO J. 1999;18:1878-1890.
Jang SJ, Park YW, Park MH, Lee JD, Lee YY, Jung TJ, Kim IS, Choi IY, Ki M, Choi BY. Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer.Eur J Surg Oncol. 1999;25:157-163.
Nielsen NH, Arnerlöv C, Cajander S, Landberg G. Cyclin E expression and proliferation in breast cancer.Anal Cell Pathol. 1998;17:177-188.
Mishina T, Dosaka-Akita H, Hommura F, Nishi M, Kojima T, Ogura S, Shimizu M, Katoh H, Kawakami Y. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers.Clin Cancer Res. 2000;6:11-16.
Quade BJ, Park JJ, Crum CP, Sun D, Dutta A. In vivo cyclin E expression as a marker for early cervical neoplasia.Mod Pathol. 1998;11:1238-1246.
Ohashi R, Gao C, Miyazaki M, Hamazaki K, Tsuji T, Inoue Y, Uemura T, Hirai R, Shimizu N, Namba M. Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.Anticancer Res. 2001;21:657-662.
Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, Nakajima M, Miwa T, Hirao T, Nakano H. Prognostic value of cyclin E and p53 expression in gastric carcinoma.Cancer. 1998;82:1238-1243.
Ling WJ, Ma YJ, Zhang WD, Chen YP. Relationship between classi-fication of spleen syndrome of patients with chronic gastric diseases and gastric carcinoma and cyclin E expression.Shijie Huaren XiaoHua Zazhi. 2000;8:513-515.
Shimizu M, Nikaido T, Toki T, Shiozawa T, Fujii S. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas.Cancer. 1999;85:669-677.
Li Z, Gao C, Ding J. [Study on seroprevalence of Helicobacter pylori infection among upper digestive tract cancer patients and their kindreds].Zhonghua Liuxingbingxue Zazhi. 1999;20:88-90.
Tabata H, Fuchigami T, Kobayashi H, Sakai Y, Nakanishi M, Tomioka K, Nakamura S, Fujishima M. Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori.Dig Dis Sci. 1999;44:2027-2034.
Meining AG, Bayerdörffer E, Stolte M. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients.Eur J Gastroenterol Hepatol. 1999;11:717-720.
Yamaoka Y, Kodama T, Kashima K, Graham DY. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.J Clin Pathol. 1999;52:215-218.
Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies.Aliment Pharmacol Ther. 1999;13:851-856.
Harris RA, Owens DK, Witherell H, Parsonnet J. Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of.H. pylori Helicobacter. 1999;4:69-76.
Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study.Scand J Gastroenterol. 1999;34:353-360.
Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer.Aliment Pharmacol Ther. 1999;13 Suppl 1:3-11.
Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils.Cancer Res. 1998;58:4255-4259.
Shirin H, Sordillo EM, Oh SH, Yamamoto H, Delohery T, Weinstein IB, Moss SF. Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells.Cancer Res. 1999;59:2277-2281.
Gao H, Wang JY, Shen XZ, Liu JJ. Effect of Helicobacter pylori infection on gastric epithelial cell proliferation.World J Gastroenterol. 2000;6:442-444.
Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury.J Gastroenterol Hepatol. 2000;15 Suppl:D46-D54.
Rudi J, Kuck D, Strand S, von Herbay A, Mariani SM, Krammer PH, Galle PR, Stremmel W. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.J Clin Invest. 1998;102:1506-1514.
Zhuang XQ, Lin SR. Research of Helicobacter pylori infection in precancerous gastric lesions.World J Gastroenterol. 2000;6:428-429.
Gu JZ, Hou TW, WAng XX. Study on precancerous gastric lesions induced by Helicobacter pylori.Shijie Huaren Xiaohua Zazhi. 2001;9:111.
Shin JY, Kim HS, Park J, Park JB, Lee JY. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.Cancer Res. 2000;60:262-265.
Carroll JS, Prall OW, Musgrove EA, Sutherland RL. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.J Biol Chem. 2000;275:38221-38229.
Fischer PM, Lane DP. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics.Curr Med Chem. 2000;7:1213-1245.
Tu JF, Jiang FZ, Chen BC. The relationship between cyclin E expres-sion in primary gallbladder carcinoma and the activity of cell proliferation.Chin J Exp Surg. 2000;17:20-21.
Huang M, Yang S, Liao S, Zhang B, You J. [The effects of cyclin E on the growth and other cell cycle related genes of breast carcinoma cells MCF-7].Zhonghua Binglixue Zazhi. 2000;29:192-195.